A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 7046-7054

  Torikai, Hiroki ^a,b   Akatsuka, Yoshiki ^a   Miyazaki, Mikinori ^a   Warren III, Edus H ^c   Oba, Taku ^d   Tsujimura, Kunio ^a   Motoyoshi, Kazuo ^b   Morishima, Yasuo ^a   Kodera, Yoshihisa ^d   Kuzushima, Kiyotaka ^a   Takahashi, Toshitada ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Fred Hutchinson Cancer Research Center   (United States)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; HLA A33, SUBTYPE A 3303; HLA-A33, SUBTYPE A-3303; ISOPROTEIN; MESSENGER RNA; THYMOSIN; THYMOSIN BETA(4);

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CHROMOSOME DELETION; FEMALE; GENE CONTROL; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RESTRICTION MAPPING; STEM CELL TRANSPLANTATION; TARGET CELL; Y CHROMOSOME; 5' UNTRANSLATED REGION; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; BIOSYNTHESIS; CELL CLONE; CHEMISTRY; CHROMOSOME MAP; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; GENE DELETION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS;

5' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BASE SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, Y; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; H-Y ANTIGEN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-A ANTIGENS; HUMANS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RNA, MESSENGER; SEQUENCE DELETION; T-LYMPHOCYTES, CYTOTOXIC; THYMOSIN;

EID: 9144272644     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.7046     Document Type: Article

References (47)

1. Simpson, E., and D. Roopenian. 1997. Minor histocompatibility antigens. Curr. Opin. Immunol. 9:655.
2. Goulmy, E. 1997. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157:125.
3. Wallny, H. J., and H. G. Rammensee. 1990. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 343:275.
4. Goulmy, E., R. Schipper, J. Pool, E. Blokland, J. H. Falkenburg, J. Vossen, A. Gratwohl, G. B. Vogelsang, H. C. van Houwelingen, and J. J. van Rood. 1996. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334:281.
5. Akatsuka, Y., E. H. Warren, T. A. Gooley, A. G. Brickner, M. T. Lin, J. A. Hansen, P. J. Martin, D. K. Madtes, V. H. Engelhard, T. Takahashi, et al. 2003. Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br. J. Haematol. 123:671.
6. Randolph, S. S., T. A. Gooley, E. H. Warren, F. R. Appelbaum, and S. R. Riddell. 2004. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103:347.
7. Socie, G., P. Loiseau, R. Tamouza, A. Janin, M. Busson, E. Gluckman, and D. Charron. 2001. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72:699.
8. Tseng, L. H., M. T. Lin, J. A. Hansen, T. Gooley, J. Pei, A. G. Smith, E. G. Martin, E. W. Petersdorf, and P. J. Martin. 1999. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 94:2911.
9. Marijt, W. A., N. A. Kernan, T. Diaz-Barrientos, W. F. Veenhof, R. J. O'Reilly, R. Willemze, and J. H. Falkenburg. 1995. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant. 16:125.
10. Voogt, P. J., W. E. Fibbe, W. A. Marijt, E. Goulmy, W. F. Veenhof, M. Hamilton, A. Brand, F. E. Zwann, R. Willemze, J. J. van Rood, et al. 1990. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335:131.
11. Horowitz, M. M., R. P. Gale, P. M. Sondel, J. M. Goldman, J. Kersey, H. J. Kolb, A. A. Rimm, O. Ringden, C. Rozman, B. Speck, et al. 1990. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555.
12. Wang, W., L. R. Meadows, J. M. den Haan, N. E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A. I. Agulnik, R. C. Hendrickson, C. E. Bishop, et al. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588.
13. Meadows, L., W. Wang, J. M. den Haan, E. Blokland, C. Reinhardus, J. W. Drijfhout, J. Shabanowitz, R. Pierce, A. I. Agulnik, C. E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273.
14. Vogt, M. H., R. A. de Paus, P. J. Voogt, R. Willemze, and J. H. Falkenburg. 2000. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95:1100.
15. Pierce, R. A., E. D. Field, J. M. den Haan, J. A. Caldwell, F. M. White, J. A. Marto, W. Wang, L. M. Frost, E. Blokland, C. Reinhardus, et al. 1999. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J. Immunol. 163:6360.
16. Warren, E. H., M. A. Gavin, E. Simpson, P. Chandler, D. C. Page, C. Disteche, K. A. Stankey, P. D. Greenberg, and S. R. Riddell. 2000. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J. Immunol. 164:2807.
17. Vogt, M. H., E. Goulmy, F. M. Kloosterboer, E. Blokland, R. A. de Paus, R. Willemze, and J. H. Falkenburg. 2000. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96:3126.
18. + T-helper cells in H-Y-mismatched transplantation. Lancet 362:610.
19. Zorn, E., D. B. Miklos, B. H. Floyd, A. Mattes-Ritz, L. Guo, R. J. Soiffer, J. H. Antin, and J. Ritz. 2004. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J. Exp. Med. 199:1133.
20. Vogt, M. H., J. W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M. G. Rester, R. A. van Soest, J. W. Drijfhout, R. Willemze, and J. H. Falkenburg. 2002. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 99:3027.
21. Lahn, B. T., and D. C. Page. 1997. Functional coherence of the human Y chromosome. Science 278:675.
22. Li, X., A. Zimmerman, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and H. L. Yin. 1996. The mouse thymosin β4 gene: structure, promoter identification, and chromosome localization. Genomics 32:388.
23. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463.
24. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038.
25. Vollrath, D., S. Foote, A. Hilton, L. G. Brown, P. Beer-Romero, J. S. Bogan, and D. C. Page. 1992. The human Y chromosome: a 43-interval map based on naturally occurring deletions. Science 258:52.
26. Akatsuka, Y., T. A. Goldberg, E. Kondo, E. G. Martin, Y. Obata, Y. Morishima, T. Takahashi, and J. A. Hansen. 2002. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 59:502.
27. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
28. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213.
29. Akatsuka, Y., T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al. 2003. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J. Exp. Med. 197:1489.
30. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
31. Falk, K., O. Rotzschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G. Jung, and H. G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40:238.
32. Gomez-Marquez, J., M. Dosil, F. Segade, X. R. Bustelo, J. G. Pichel, F. Dominguez, and M. Freire. 1989. Thymosin-β4 gene: preliminary characterization and expression in tissues, thymic cells, and lymphocytes. J. Immunol. 143:2740.
33. Kuttler, C., A. K. Nussbaum, T. P. Dick, H. G. Rammensee, H. Schild, and K. P. Hadeler. 2000. An algorithm for the prediction of proteasomal cleavages. J. Mol. Biol. 298:417.
34. Nussbaum, A. K., C. Kuttler, K. P. Hadeler, H. G. Rammensee, and H. Schild. 2001. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 53:87.
35. Uenaka, A., T. Ono, T. Akisawa, H. Wada, T. Yasuda, and E. Nakayama. 1994. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J. Exp. Med. 180:1599.
36. Burge, C., and S. Karlin. 1997. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268:78.
37. Yewdell, J. W., L. C. Anton, and J. R. Bennink. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157:1823.
38. Schubert, U., L. C. Anton, J. Gibbs, C. C. Norbury, J. W. Yewdell, and J. R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770.
39. Clark, E. A., T. R. Golub, E. S. Lander, and R. O. Hynes. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532.
40. den Haan, J. M., L. M. Meadows, W. Wang, J. Pool, E. Blokland, T. L. Bishop, C. Reinhardus, J. Shabanowitz, R. Offringa, D. F. Hunt, et al. 1998. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054.
41. Spierings, E., A. G. Brickner, J. A. Caldwell, S. Zegveld, N. Tatsis, E. Blokland, J. Pool, R. A. Pierce, S. Mollah, J. Shabanowitz, et al. 2003. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102:621.
42. Pierce, R. A., E. D. Field, T. Mutis, T. N. Golovina, C. Von Kap-Herr, M. Wilke, J. Pool, J. Shabanowitz, M. J. Pettenati, L. C. Eisenlohr, et al. 2001. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J. Immunol. 167:3223.
43. Spierings, E., B. Wieles, and E. Goulmy. 2004. Minor histocompatibility antigens: big in tumour therapy. Trends Immunol. 25:56.
44. Dolstra, H., B. de Rijke, H. Fredrix, A. Balas, F. Maas, F. Scherpen, M. J. Aviles, J. L. Vicario, N. J. Beekman, F. Ossendorp, et al. 2002. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur. J. Immunol. 32:2748.
45. Dolstra, H., H. Fredrix, F. Maas, P. G. Coulie, F. Brasseur, E. Mensink, G. J. Adema, T. M. de Witte, C. G. Figdor, and E. van de Wiel-van Kemenade. 1999. A human minor histocompatibility antigen specific for B cell acute lyniphoblastic leukemia. J. Exp. Med. 189:301.
46. Schwab, S. R., K. C. Li, C. Kang, and N. Shastri. 2003. Constitutive display of cryptic translation products by MHC class I molecules. Science 301:1367.
47. Hickman, H. D., A. D. Luis, R. Buchli, S. R. Few, M. Sathiamurthy, R. S. VanGundy, C. F. Giberson, and W. H. Hildebrand. 2004. Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J. Immunol. 172:2944.